ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For...
ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For...
ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For ImmunityBio's Trial Investigators
ImmunityBio與nCartes達成合作協議，旨在自動化和簡化臨床試驗的數據履行過程；合作的目標是使這一重要過程對ImmunityBio的試驗研究人員更加簡單、快速和經濟。
ImmunityBio, Inc. (NASDAQ:IBRX), a vertically integrated biotechnology company, and nCartes, Inc., a transformational cloud software platform provider, announced a collaboration agreement aimed at automating and streamlining the data fulfillment process for clinical trials. The goal of the collaboration is to make this essential process easier, faster, and less expensive for ImmunityBio's trial investigators.
ImmunityBio, Inc.（納斯達克：IBRX）是一家垂直整合的生物技術公司，而nCartes, Inc.是一家變革性的雲軟件平台提供商，兩者宣佈達成一項合作協議，旨在自動化和簡化臨床試驗的數據履行過程。合作的目標是使這一重要過程對ImmunityBio的試驗研究人員更加簡單、快速和經濟。
The vast majority of clinical trials today gather data manually at clinical research sites. The data is then entered by hand into Electronic Data Capture (EDC) systems used by clinical trial sponsors. This process is time-consuming, costly, and creates the potential for errors that can further delay trial results. This new collaboration will instead rely on using digital information available in source electronic medical record (EMR) systems to directly populate EDC systems.
目前絕大多數臨床試驗都是在臨床研究現場手動收集數據。然後，這些數據通過手動方式輸入到臨床試驗贊助商使用的電子數據採集（EDC）系統中。這個過程耗時、成本高，並且可能出現錯誤，從而進一步延誤試驗結果。這項新的合作將依賴使用可在源電子病歷（EMR）系統中獲得的數字信息，直接填充EDC系統。